BrainStorm Strengthens Exosome Patent Portfolio Receives Notice of Allowance for U.S. Patent Covering Its Platform Technology
| BCLI Stock | USD 1.91 0.12 5.91% |
Under 62% of Brainstorm Cell's investor base is looking to short. The analysis of the overall investor sentiment regarding Brainstorm Cell Therapeutics suggests that many traders are alarmed. Brainstorm Cell's investing sentiment shows overall attitude of investors towards Brainstorm Cell Therapeutics.
Brainstorm |
BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today that it has received Notice of Allowance from the U.S. Patent Trademark Office for patent application 16981,757 which covers its proprietary exosome technology.
Read at finance.yahoo.com
 |
Brainstorm Cell Fundamental Analysis
We analyze Brainstorm Cell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brainstorm Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brainstorm Cell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
Brainstorm Cell is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Brainstorm Cell Ther Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Brainstorm Cell stock to make a market-neutral strategy. Peer analysis of Brainstorm Cell could also be used in its relative valuation, which is a method of valuing Brainstorm Cell by comparing valuation metrics with similar companies.
Peers
Brainstorm Cell Related Equities
| HCWB | HCW Biologics | 7.69 | ||||
| CUE | Cue Biopharma | 6.62 | ||||
| XFOR | X4 Pharmaceuticals | 6.06 | ||||
| GRI | GRI Bio | 4.76 | ||||
| ALDX | Aldeyra | 4.25 | ||||
| MREO | Mereo BioPharma | 2.73 | ||||
| BCAB | Bioatla | 2.17 | ||||
| PLX | Protalix Biotherapeutics | 2.10 | ||||
| CELC | Celcuity LLC | 1.96 | ||||
| CRVS | Corvus Pharmaceuticals | 1.32 | ||||
| TRVI | Trevi Therapeutics | 1.03 | ||||
| HOWL | Werewolf Therapeutics | 0.75 | ||||
| EWTX | Edgewise Therapeutics | 0.07 | ||||
| CNTB | Connect Biopharma | 1.02 | ||||
| INZY | Inozyme Pharma | 1.37 | ||||
| CKPT | Checkpoint Therapeutics | 1.73 | ||||
| ANTX | AN2 Therapeutics | 2.56 | ||||
| GBIO | Generation Bio | 3.70 | ||||
| DAWN | Day One | 3.81 | ||||
| TERN | Terns Pharmaceuticals | 3.88 | ||||
| PASG | Passage Bio | 4.92 | ||||
| CCCC | C4 Therapeutics | 5.71 |
Complementary Tools for Brainstorm Stock analysis
When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |